2,669 Marsh & McLennan Companies, Inc. $MRSH Shares Bought by Calamos Advisors LLC

Calamos Advisors LLC lifted its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 2.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 131,938 shares of the financial services provider’s stock after purchasing an additional 2,669 shares during the period. Calamos Advisors LLC’s holdings in Marsh & McLennan Companies were worth $22,526,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Focus Partners Advisor Solutions LLC purchased a new position in shares of Marsh & McLennan Companies in the 2nd quarter valued at about $2,153,000. Daiichi Life Insurance Co. Ltd. purchased a new stake in Marsh & McLennan Companies during the second quarter worth about $3,880,000. Korea Investment CORP acquired a new position in Marsh & McLennan Companies during the second quarter worth about $46,856,000. Bank of Nova Scotia purchased a new position in Marsh & McLennan Companies in the second quarter valued at about $20,681,000. Finally, Royal Bank of Canada increased its holdings in Marsh & McLennan Companies by 4.7% in the first quarter. Royal Bank of Canada now owns 3,316,579 shares of the financial services provider’s stock valued at $575,261,000 after buying an additional 148,884 shares in the last quarter. 87.99% of the stock is owned by institutional investors.

Insider Buying and Selling at Marsh & McLennan Companies

In other Marsh & McLennan Companies news, VP Stacy Mills sold 1,215 shares of the firm’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $200.00, for a total transaction of $243,000.00. Following the completion of the transaction, the vice president owned 2,705 shares of the company’s stock, valued at approximately $541,000. This trade represents a 30.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Dean Klisura sold 4,194 shares of the business’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $200.00, for a total value of $838,800.00. Following the completion of the transaction, the chief executive officer directly owned 20,935 shares of the company’s stock, valued at approximately $4,187,000. This trade represents a 16.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on MRSH shares. Bank of America decreased their price target on Marsh & McLennan Companies from $179.00 to $178.00 and set an “underperform” rating on the stock in a research note on Wednesday, July 15th. The Goldman Sachs Group dropped their price objective on Marsh & McLennan Companies from $197.00 to $191.00 and set a “neutral” rating for the company in a research note on Thursday, October 1st. Wells Fargo & Company lifted their price objective on Marsh & McLennan Companies from $183.00 to $197.00 and gave the stock an “equal weight” rating in a report on Friday, October 16th. Citigroup boosted their target price on Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “neutral” rating in a research report on Friday, October 16th. Finally, Mizuho upped their target price on Marsh & McLennan Companies from $190.00 to $200.00 and gave the company a “neutral” rating in a report on Monday, October 19th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Marsh & McLennan Companies presently has a consensus rating of “Hold” and a consensus price target of $205.84.

More Marsh & McLennan Companies News

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $11.39 from $11.23 and FY2028 to $12.28 from $12.13. It also nudged several quarterly forecasts higher. These revisions point to improving expectations for earnings growth, though they are one research firm’s estimates.
• Positive Sentiment: BMO Capital Markets raised MRSH to Outperform, a favorable analyst rating that may bolster investor sentiment. Read article: Marsh & McLennan Companies Raised to Outperform at BMO Capital Markets
• Positive Sentiment: A published valuation analysis says MRSH may be 27% undervalued following the AltamarCAM deal, suggesting potential upside if investors agree with its assessment. Read article: Marsh Stock May Be 27% Undervalued Following AltamarCAM Deal
• Neutral Sentiment: Marsh appointed Marcus Baker chairman and Michael Walls global head of Marine, Cargo, and Logistics. The leadership changes may be relevant to the business, but the report provides no financial details indicating an immediate earnings impact. Read article: Marsh & McLennan appoints Marcus Baker and Michael Walls
• Negative Sentiment: Zacks lowered its Q4 2026 EPS estimate to $2.15 from $2.19 and Q3 2027 to $2.19 from $2.21. Its FY2026 estimate of $10.43 also remains below the cited consensus of $10.48, indicating some near-term caution.

Marsh & McLennan Companies Trading Down 2.5%

Shares of MRSH opened at $204.29 on Friday. Marsh & McLennan Companies, Inc. has a 12-month low of $156.60 and a 12-month high of $214.00. The firm has a market capitalization of $97.14 billion, a PE ratio of 24.44, a P/E/G ratio of 2.77 and a beta of 0.53. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 1.27. The business’s 50-day simple moving average is $183.78.

Marsh & McLennan Companies (NYSE:MRSH) last issued its quarterly earnings data on Thursday, October 15th. The financial services provider reported $2.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.96 by $0.07. Marsh & McLennan Companies had a net margin of 14.20% and a return on equity of 33.32%. The business had revenue of $6.86 billion during the quarter. Marsh & McLennan Companies’s revenue for the quarter was up 8.1% on a year-over-year basis. As a group, analysts forecast that Marsh & McLennan Companies, Inc. will post 10.49 EPS for the current fiscal year.

Marsh & McLennan Companies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.99 per share. This represents a $3.96 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Thursday, October 1st. Marsh & McLennan Companies’s dividend payout ratio is 47.37%.

About Marsh & McLennan Companies

Marsh & McLennan Companies, now known as Marsh, is a professional services firm focused on risk, strategy and people. Its businesses help organizations assess and manage risk, arrange insurance and reinsurance, and address workforce and organizational challenges.

The company operates through Marsh, an insurance brokerage and risk advisory business; Guy Carpenter, which specializes in reinsurance and related risk services; Mercer, which provides health, wealth and career consulting; and Oliver Wyman, a management consulting firm.